Teleflex Incorporated (NYSE:TFX) records a mixed performance over the past three years with a notable
stock underperformance despite significant investments and acquisitions. However, it has also seen financial variables trending positively with its earnings either meeting or surpassing estimates. The corporation is investing heavily into AI technology, specifically with o9’s AI-Powered platform for business planning and supply chain management. Several financial firms such as Thrivent Financial for Lutherans, Lighthouse Investment Partners, and Armistice Capital have invested or extended their shares in Teleflex. The company has also announced second quarter 2024 results, plans for a quarterly dividend, and has raised its 2024 outlook. On the innovation front, Teleflex’s
Barrigel Rectal Spacer is gaining momentum and will be highlighted in three presentations at the 2024 ASTRO Annual Meeting.
Q4 2024 earnings forecast for Teleflex has been issued by Zacks Research and the stock appears to be a strong candidate for long term portfolio addition.
Teleflex’s acquisition of Palette Life Sciences is expected to boost its urology portfolio.
Teleflex Incorporated TFX News Analytics from Wed, 17 Aug 2016 20:09:17 GMT to Sun, 29 Sep 2024 15:19:13 GMT -
Rating 4
- Innovation 5
- Rumor 5
